This inventor holds 1 USPTO granted patent. Top assignees: Il-Yang Pharm. Co., Ltd, Industry-Academic Cooperation Foundation, Sookmyung Women's University, Samsung Life Public Welfare Foundation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Hee Jong Kim: Innovator in Anti-Inflammatory Peptides
Introduction
Hee Jong Kim is a notable inventor based in Asan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptides with anti-inflammatory properties. His innovative work has the potential to impact the treatment of various inflammatory diseases.
Latest Patents
Hee Jong Kim holds a patent for "Peptides and use thereof." This invention focuses on novel peptides that exhibit anti-inflammatory effects. The patent encompasses a polynucleotide encoding the peptide, a pharmaceutical composition for preventing or treating inflammatory diseases, and various applications including over-the-counter drug compositions and health food formulations aimed at alleviating inflammation. Additionally, it outlines methods for treating inflammatory diseases and designing peptide mimetics.
Career Highlights
Throughout his career, Hee Jong Kim has worked with prominent organizations such as the Samsung Life Public Welfare Foundation and Il-yang Pharm. Co., Ltd. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in health-related products.
Collaborations
Hee Jong Kim has collaborated with talented individuals in his field, including Dae Ho Cho and Min Kyung Jung. Their combined efforts have fostered a productive environment for innovation and research in anti-inflammatory treatments.
Conclusion
Hee Jong Kim's work in developing peptides for anti-inflammatory applications showcases his dedication to advancing medical science. His contributions are poised to make a meaningful difference in the treatment of inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile